Evidence map›Paper›PMID 41208996›Full record

ArticleFrontiers in immunology2025

Impaired NLRP3 inflammasome signaling diverts pyroptotic to apoptotic caspase activation in macrophages.

Ying-Qing Gan, Yuan-Wen Cai, Xiu-Wen Liang, Ling-Zhi Wang, Fu-Li Shi, Nuo Sun, Ya-Ping Li, Rong Xu, Bo Hu, Qing-Bing Zha and 4 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Caspase-1 in cancer and inflammatory diseases: a potential therapeutic target.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ying-Qing Gan *Department of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Yuan-Wen Cai *Department of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Xiu-Wen Liang *Department of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Ling-Zhi WangDepartment of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Fu-Li ShiDepartment of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Nuo SunDepartment of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Ya-Ping LiDepartment of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Rong XuDepartment of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Bo HuDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Qing-Bing ZhaGuangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, the Fifth Affiliated Hospital (Heyuan Shenhe People's Hospital), Jinan University, Heyuan, China.
Xian-Hui HeDepartment of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Tak-Sui WongDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Jin-Hua LiDepartment of Ultrasound, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Dong-Yun OuyangDepartment of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NLRP3 (NLR family pyrin domain-containing 3) inflammasome is a first line of defense of innate immunity, mediating caspase-1-dependent pyroptosis and cytokine release upon danger signaling. Intervention of NLRP3 innate surveillance may cause defects in this signaling pathway, while the host has evolved alternative ways to combat such intervention. Yet it remains incompletely understood whether NLRP3 sensing of danger signaling can divert pyroptosis to other forms of cell death in circumstances of impaired NLRP3 signaling. In this study, we adopted two macrophage models (delayed delivery of triggering signaling and caspase-1 deficiency) to mimic defects in NLRP3 signaling to address this issue. We found that the NLRP3/ASC platform preferentially recruited caspase-1 rather than caspase-8 in lipopolysaccharide (LPS)-primed macrophages timely triggered with nigericin. However, when the triggering signal (nigericin) was delayed, the recruitment diverted to caspase-8, leading to apoptotic caspase activation. Furthermore, in caspase-1-deficient macrophages, nigericin triggering diverted NLRP3-ASC-caspase-1-driven pyroptosis to caspase-8/-9/-3 activation and GSDME-mediated secondary necrosis. Unexpectedly, VX-765 (a caspase-1 inhibitor) exhibited a pan-caspase inhibitor-like effect, suppressing caspase-8/-9/-3 activation and GSDME cleavage in a dose-dependent manner. Mitochondrial damage was observed in both WT and caspase-1-deficient cells upon nigericin stimulation, suggesting mitochondrial injury being an upstream event in this process. Collectively, our data indicate that NLRP3 inflammasome is poised to divert pyroptotic to apoptotic caspase activation for combating danger signaling when conventional pathway is impaired, highlighting a complex interaction between various forms of cell death pathways.

Indexed as

ApoptosisInflammasomesMacrophagesNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisSignal TransductionAnimalsCaspase 1Caspase 8Enzyme ActivationLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutNigericinCasp1 protein, mouseCaspase 1Caspase 8InflammasomesLipopolysaccharidesNigericinNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseapoptosisapoptosomecaspase-8LPS toleranceNLRP3 inflammasomepyroptosis

Identifiers

PMID41208996
PMCPMC12591955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.